Skip to content

Use of Synvisc® in Knee Osteoarthritis - Medico-economical Study

Use of Synvisc® in Knee Osteoarthritis - Medico-economical Study (U.S.A.G.E. Médico-Economique)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02195505
Enrollment
374
Registered
2014-07-21
Start date
2001-09-30
Completion date
Unknown
Last updated
2014-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Brief summary

The USAGE study aims at assessing on a long-term period (two years in average) the outcome in clinical or economical term of patients with knee osteoarthritis (OA) treated or not with Synvisc®, in the 1139.4 clinical trial.

Interventions

None listed

Sponsors

Boehringer Ingelheim
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients have already been followed up on a nine-month period in a pragmatic medica-economical clinical trial (BI Trial No.: 1139.4)

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Change in Lequesne indexup to 2 yearsassessment of algo-functional severity of pathology
Change in Womac indexup to 2 yearsassessment of symptom severity

Secondary

MeasureTime frame
Medical costs related to knee osteoarthritisup to 2 years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026